Candriam SCA’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $59.1M | Buy |
555,131
+153,396
| +38% | +$18.6M | 0.27% | 78 |
|
|
2026
Q1 | $65.7M | Buy |
401,735
+693
| +0.2% | +$107K | 0.34% | 61 |
|
|
2025
Q4 | $69.8M | Buy |
401,042
+3,454
| +0.9% | +$630K | 0.35% | 61 |
|
|
2025
Q3 | $57.3M | Sell |
397,588
-41,100
| -9% | -$5.03M | 0.3% | 79 |
|
|
2025
Q2 | $44.2M | Sell |
438,688
-16,720
| -4% | -$1.28M | 0.25% | 91 |
|
|
2025
Q1 | $34.7M | Buy |
455,408
+1,888
| +0.4% | +$144K | 0.22% | 101 |
|
|
2024
Q4 | $31.3M | Sell |
453,520
-22,974
| -5% | -$1.65M | 0.18% | 110 |
|
|
2024
Q3 | $34.8M | Sell |
476,494
-79,440
| -14% | -$5.86M | 0.2% | 112 |
|
|
2024
Q2 | $37.2M | Buy |
555,934
+165,734
| +42% | +$6.43M | 0.23% | 97 |
|
|
2024
Q1 | $10.6M | Buy |
390,200
+80,000
| +26% | +$2.24M | 0.07% | 249 |
|
|
2023
Q4 | $9.61M | Sell |
310,200
-15,000
| -5% | -$389K | 0.07% | 254 |
|
|
2023
Q3 | $8.21M | Sell |
325,200
-482,000
| -60% | -$11M | 0.06% | 252 |
|
|
2023
Q2 | $17M | Sell |
807,200
-189,892
| -19% | -$3.6M | 0.12% | 179 |
|
|
2023
Q1 | $15.6M | Sell |
997,092
-55,108
| -5% | -$1.07M | 0.11% | 198 |
|
|
2022
Q4 | $21M | Hold |
1,052,200
| – | – | 0.14% | 161 |
|
|
2022
Q3 | $22.7M | Sell |
1,052,200
-830,248
| -44% | -$19.9M | 0.16% | 145 |
|
|
2022
Q2 | $37.1M | Buy |
1,882,448
+423,974
| +29% | +$8.88M | 0.31% | 81 |
|
|
2022
Q1 | $34.3M | Buy |
1,458,474
+492,719
| +51% | +$11.4M | 0.23% | 101 |
|
|
2021
Q4 | $26.3M | Buy |
965,755
+86,208
| +10% | +$2.46M | 0.17% | 142 |
|
|
2021
Q3 | $24.2M | Buy |
879,547
+374,306
| +74% | +$9.82M | 0.16% | 143 |
|
|
2021
Q2 | $14.4M | Buy |
505,241
+222,340
| +79% | +$6.6M | 0.1% | 234 |
|
|
2021
Q1 | $9.05M | Hold |
282,901
| – | – | 0.08% | 269 |
|
|
2020
Q4 | $9.42M | Sell |
282,901
-9,099
| -3% | -$332K | 0.07% | 275 |
|
|
2020
Q3 | $9.38M | Hold |
292,000
| – | – | 0.09% | 249 |
|
|
2020
Q2 | $8.04M | Buy |
+292,000
| New | +$6.92M | 0.08% | 250 |
|
|
2019
Q1 | – | Sell |
-70,567
| Closed | -$926K | – | 814 |
|
|
2018
Q4 | $926K | Sell |
70,567
-150
| -0.2% | -$2.39K | 0.01% | 594 |
|
|
2018
Q3 | $1.45M | Sell |
70,717
-24,350
| -26% | -$550K | 0.02% | 560 |
|
|
2018
Q2 | $2.25M | Buy |
+95,067
| New | +$2.45M | 0.04% | 462 |
|
|
2016
Q3 | – | Sell |
-75,000
| Closed | -$740K | – | 668 |
|
|
2016
Q2 | $740K | Hold |
75,000
| – | – | 0.02% | 496 |
|
|
2016
Q1 | $945K | Sell |
75,000
-133,800
| -64% | -$1.76M | 0.02% | 437 |
|
|
2015
Q4 | $3.79M | Buy |
208,800
+60,000
| +40% | +$1.06M | 0.1% | 216 |
|
|
2015
Q3 | $2.76M | Sell |
148,800
-17,200
| -10% | -$429K | 0.07% | 298 |
|
|
2015
Q2 | $4.05M | Sell |
166,000
-24,000
| -13% | -$545K | 0.08% | 272 |
|
|
2015
Q1 | $3.95M | Sell |
190,000
-30,000
| -14% | -$529K | 0.08% | 293 |
|
|
2014
Q4 | $3.4M | Buy |
+220,000
| New | +$3.12M | 0.07% | 292 |
|
Other funds holding INSM
BBA
DGM
OAG
Candriam SCA's INSM Position: Q2 2026 in Review
Candriam SCA increased its Insmed (INSM) stake by 38% in Q2 2026, buying an estimated $18.6M and bringing the position to 555,131 shares worth $59.1M. The position accounts for 0.27% of the portfolio, ranked #78.
Candriam SCA first reported a position in INSM in Q4 2014 and has held it in 35 quarters since. The position peaked at $69.8M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Candriam SCA held 555,131 shares of Insmed worth $59.1M as of Q2 2026.
- Candriam SCA bought 153,396 Insmed shares in Q2 2026, an estimated $18.6M.
- Insmed made up 0.27% of Candriam SCA's portfolio in Q2 2026, its #78 holding.
- Candriam SCA first reported a position in Insmed in Q4 2014 and has held it in 35 quarters since.
- Candriam SCA's Insmed position peaked at $69.8M in Q4 2025.
- 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.